226 related articles for article (PubMed ID: 15191896)
1. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation.
Chandler MP; Kerner J; Huang H; Vazquez E; Reszko A; Martini WZ; Hoppel CL; Imai M; Rastogi S; Sabbah HN; Stanley WC
Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1538-43. PubMed ID: 15191896
[TBL] [Abstract][Full Text] [Related]
2. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.
Osorio JC; Stanley WC; Linke A; Castellari M; Diep QN; Panchal AR; Hintze TH; Lopaschuk GD; Recchia FA
Circulation; 2002 Jul; 106(5):606-12. PubMed ID: 12147544
[TBL] [Abstract][Full Text] [Related]
3. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
[TBL] [Abstract][Full Text] [Related]
4. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
[TBL] [Abstract][Full Text] [Related]
5. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.
Sharma V; Dhillon P; Wambolt R; Parsons H; Brownsey R; Allard MF; McNeill JH
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1609-20. PubMed ID: 18203848
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes.
Prip-Buus C; Pegorier JP; Duee PH; Kohl C; Girard J
Biochem J; 1990 Jul; 269(2):409-15. PubMed ID: 2167069
[TBL] [Abstract][Full Text] [Related]
7. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
[TBL] [Abstract][Full Text] [Related]
8. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
Lionetti V; Linke A; Chandler MP; Young ME; Penn MS; Gupte S; d'Agostino C; Hintze TH; Stanley WC; Recchia FA
Cardiovasc Res; 2005 Jun; 66(3):454-61. PubMed ID: 15914110
[TBL] [Abstract][Full Text] [Related]
9. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle.
Rasmussen BB; Holmbäck UC; Volpi E; Morio-Liondore B; Paddon-Jones D; Wolfe RR
J Clin Invest; 2002 Dec; 110(11):1687-93. PubMed ID: 12464674
[TBL] [Abstract][Full Text] [Related]
10. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.
Hall JL; Lopaschuk GD; Barr A; Bringas J; Pizzurro RD; Stanley WC
Cardiovasc Res; 1996 Nov; 32(5):879-85. PubMed ID: 8944819
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
Sugden MC; Priestman DA; Orfali KA; Holness MJ
Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
[TBL] [Abstract][Full Text] [Related]
12. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
13. Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs.
Schmidt I; Herpin P
J Nutr; 1998 May; 128(5):886-93. PubMed ID: 9566999
[TBL] [Abstract][Full Text] [Related]
14. Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure.
Qanud K; Mamdani M; Pepe M; Khairallah RJ; Gravel J; Lei B; Gupte SA; Sharov VG; Sabbah HN; Stanley WC; Recchia FA
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2098-105. PubMed ID: 18820029
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure.
Lei B; Lionetti V; Young ME; Chandler MP; d'Agostino C; Kang E; Altarejos M; Matsuo K; Hintze TH; Stanley WC; Recchia FA
J Mol Cell Cardiol; 2004 Apr; 36(4):567-76. PubMed ID: 15081316
[TBL] [Abstract][Full Text] [Related]
16. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
17. Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart.
Onay-Besikci A; Campbell FM; Hopkins TA; Dyck JR; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H283-9. PubMed ID: 12388233
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.
King KL; Okere IC; Sharma N; Dyck JR; Reszko AE; McElfresh TA; Kerner J; Chandler MP; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1033-7. PubMed ID: 15821035
[TBL] [Abstract][Full Text] [Related]
19. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
20. beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content.
Stanley WC; Meadows SR; Kivilo KM; Roth BA; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1626-31. PubMed ID: 12969881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
